Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 11;23(22):13929.
doi: 10.3390/ijms232213929.

Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies

Michael Gabel  1   2 , Annkathrin Knauss  1   2 , Dagmar Fischer  3 , Markus F Neurath  4   5 , Benno Weigmann  1   2
Affiliations
Review

Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies

Michael Gabel et al. Int J Mol Sci. .

Abstract

The mechanism of RNA interference (RNAi) could represent a breakthrough in the therapy of all diseases that arise from a gene defect or require the inhibition of a specific gene expression. In particular, small interfering RNA (siRNA) offers an attractive opportunity to achieve a new milestone in the therapy of human diseases. The limitations of siRNA, such as poor stability, inefficient cell uptake, and undesired immune activation, as well as the inability to specifically reach the target tissue in the body, can be overcome by further developments in the field of nanoparticulate drug delivery. Therefore, types of surface modified siRNA nanoparticles are presented and illustrate how a more efficient and safer distribution of siRNA at the target site is possible by modifying the surface properties of nanoparticles with antibodies. However, the development of such efficient and safe delivery strategies is currently still a major challenge. In consideration of that, this review article aims to demonstrate the function and targeted delivery of siRNA nanoparticles, focusing on the surface modification via antibodies, various lipid- and polymer-components, and the therapeutic effects of these delivery systems.

Keywords: antibody; gene delivery; lipid nanoparticle; polymer nanoparticle; siRNA; surface-functionalized nanoparticles; targeted drug delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Schematic illustration about the challenges, barriers and the mechanism of action of siRNA in the cell. Furthermore, the figure shows the journey of siRNA starting at the injection site to the cell cytosol, where siRNA can exert its pharmacological effect. The description is in the box inside the picture.
Figure 2
Figure 2
The schematic illustration shows possible surface design options in polymer- and lipid- based siRNA nanoparticles. For simplicity, no distinction was made between lipid- and polymer-NP. In addition, this illustration shows an optimal orientation of the antibodies and antibody fragments with an unhindered antigen recognition site. Furthermore, possible ways to conjugate antibodies or antibody components directly on the surface or on linking compounds of the surface are presented.
See this image and copyright information in PMC

References

    1. Fire A., Xu S.Q., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811. doi: 10.1038/35888. - DOI - PubMed
    1. Weng Y.H., Xiao H.H., Zhang J.C., Liang X.J., Huang Y.Y. RNAi therapeutic and its innovative biotechnological evolution. Biotechnol. Adv. 2019;37:801–825. doi: 10.1016/j.biotechadv.2019.04.012. - DOI - PubMed
    1. Napoli C., Lemieux C., Jorgensen R. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in Trans. Plant Cell. 1990;2:279–289. doi: 10.2307/3869076. - DOI - PMC - PubMed
    1. Vanblokland R., Vandergeest N., Mol J.N.M., Kooter J.M. Transgene-Mediated Suppression of Chalcone Synthase Expression in Petunia-Hybrida Results from an Increase in Rna Turnover. Plant J. 1994;6:861–877. doi: 10.1046/j.1365-313X.1994.6060861.x. - DOI
    1. Bernards R. The Nobel Prize in Physiology or Medicine for 2006 for the discovery of RNA interference. Ned. Tijdschr. Geneeskd. 2006;150:2849–2853. - PubMed

LinkOut - more resources